Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The Axsome SOL-BED-301 Study is looking at how well an investigational study drug works for people living with Binge Eating Disorder (BED).
Binge eating disorder is characterized by recurrent episodes of binge eating, which include:
In this study, doctors want to evaluate the safety and effectiveness of an oral investigational drug. Researchers want to compare the investigational drug to placebo, which looks like the investigational drug but contains no active medication.
The investigational drug is not approved to treat BED. You may not directly benefit from participating in this study. However, the results of this study will provide more information about the investigational drug and whether it could one day be approved to treat BED.
Clinical Trials Listing: https://clinicaltrials.gov/study/NCT06413433
This study is being carried out to:
If you take part, you will:
It’s possible you could benefit from study participation, but this cannot be guaranteed. However, your study participation could help people with BED in the future.
You may also experience one or more side effects during this study. Prior to you beginning study participation, the study staff will review known study-related risks and side effects with you.
Throughout the study, you will be closely monitored for any study-related side effects or changes in your health.
Additional criteria will apply. All study-related visits, tests, and drugs will be provided at no cost. You may also be reimbursed for study-related travel expenses.
Please complete the form below, and a member of our study team will reach out to you.
160 West Street Suite 1A | Cromwell, CT 06416 | Phone: (860) 632-0144 | Copyright © 2024 CT Clinical Research - All Rights Reserved